TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE
Clinical trials for TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE explained in plain language.
Never miss a new study
Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE trials appear
Sign up with your email to follow new studies for TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare joint tumor and advanced cancers
Disease control OngoingThis study tests an experimental drug called vimseltinib in people with advanced solid tumors or a rare joint tumor called tenosynovial giant cell tumor (TGCT). The goal is to find the safest dose and see if the drug shrinks tumors or improves joint movement. About 120 adults wil…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE
Phase: PHASE1, PHASE2 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New pill could shrink rare joint tumors without surgery
Disease control OngoingThis study tests an experimental drug called vimseltinib for people with tenosynovial giant cell tumor (TGCT), a rare but painful joint tumor that can't be removed surgically. About 123 adults with moderate to severe pain or stiffness will receive either the drug or a placebo for…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR, DIFFUSE
Phase: PHASE3 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 14, 2026 12:01 UTC